Through Nobel Guard, the sequence listing of numerous rare diseases could be analyzed in detail at once. (Image : PublicDomainPictures / Pixabay)
SEOUL, Nov.24 (Korea Bizwire) – KT announced that through collaboration with Lab Genomics, a company specializing in the analysis of genes, they will be launching ‘Nobel Guard’, a machine which screens genetic conditions that cause development disorders among children.
Nobel Guard was created with KT’s aptitude in analyzing big data, and the next generation sequence listing analysis technology of Lab Genomics. To spot 50 different development disorders at an early stage, a data base of 300,005,000 cases was established.
Through Nobel Guard, the sequence listing of numerous rare diseases could be analyzed in detail at once. (Image : Yonhap)
Through Nobel Guard, the sequence listing of numerous rare diseases could be analyzed in detail at once.
Checkups through Lab Genomics can be done at large hospitals, obstetricians and pediatric hospitals. Further information could be known by calling Lab Genomics(☎031-628-0700).
By M.H.Lee (mhlee@koreabizwire.com)
